These courts in L.A. and elsewhere operate on models built around male patterns of addiction and accountability. Hawaii tried ...

Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a clinical-stage biopharmaceutical company developing nature-derived psychedelic therapeutics, today announced that the first ...

Seasoned Biopharma leader bringing deep commercial experience to shape and inform corporate strategy, clinical trial design ...

We are building Definium to be a leader in psychiatry, focused on delivering a differentiated, scalable franchise for patients with depression, anxiety, and trauma, anchored by DT120 ODT, which we ...

De Novo FDA submission for moderate-to-severe insomnia HOUSTON, TX, April 22, 2026 (GLOBE NEWSWIRE)-- Nexalin Technology, Inc. (Nasdaq: NXL) (the “Company” or “Nexalin”), the leader in non-invasive ...

Cartesian Therapeutics' lead asset, Descartes-08, demonstrated a 7.1-point MG-ADL reduction at 12 months in Phase 2b. Find ...

Nexalin Technology, Inc. (Nasdaq: NXL) (the "Company" or "Nexalin"), the leader in non-invasive Deep Intracranial Frequency Stimulation (DIFS) of the brain ...

Researchers and clinicians investigating topical insulin in eye care discuss their research and its potential future ...

Top VR Games Releasing in 2025. Get ready, because 2025 is shaping up to be a massive year for virtual reality gaming. We’re ...

A randomized controlled trial in Turkey found that high school students given unrestricted access to generative AI for math practice performed worse on later independent exams than peers without AI ...

Blood-pressure reduction is the only proven treatment to prevent stroke. Whether a single pill that combines three antihypertensive drugs at low doses, in addition to standard antihypertensive ...